By Counterforce Health Team in Cabometyx (cabozantinib) —

How to Get Cabometyx (cabozantinib) Covered by Humana in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cabometyx Covered by Humana in Virginia

Cabometyx (cabozantinib) requires prior authorization from Humana in Virginia and is typically covered as a Tier 5 specialty drug under Medicare Advantage Part D plans. The fastest path to approval: 1) Verify your plan's formulary status via the Humana provider portal, 2) Have your oncologist submit a complete PA request with diagnosis, staging, prior therapies, and NCCN guideline support, and 3) Request expedited review (24-72 hours) for urgent cancer cases. If denied, Virginia's State Corporation Commission Bureau of Insurance offers external review with high overturn potential for specialty drug appeals.

Table of Contents

Before You Start: Plan Verification

First, confirm your Humana plan type and Cabometyx's coverage status. Call the member services number on your insurance card or log into your member portal to verify:

  • Plan type: Medicare Advantage, Dual Special Needs Plan (D-SNP), or Medicaid
  • Formulary tier: Cabometyx is typically Tier 5 (specialty) with high copays
  • Prior authorization requirement: Required for all Humana plans
  • Specialty pharmacy network: Must use Humana-approved specialty pharmacy
Important: Cabometyx tablets and Cometriq capsules are not interchangeable. Ensure your prescription specifies the correct formulation to avoid automatic denials.

Coverage at a Glance

Requirement Details Where to Find Source
Prior Authorization Mandatory for all plans Submit via provider portal or fax Humana PA Lists
Formulary Status Tier 5 specialty drug Member portal or formulary lookup Humana Pharmacy Resources
Approved Indications RCC (first-line combo/monotherapy), HCC post-sorafenib, RAI-refractory DTC FDA prescribing information FDA Access Data
Specialty Pharmacy Required via Humana network Humana Pharmacy Solutions PA Medication Approvals
Appeal Deadline 180 days for internal; 120 days for external Virginia insurance law VA Code § 38.2-3561

Step-by-Step: Fastest Path to Approval

1. Verify Benefits and Formulary Status

Who: Patient or clinic staff
Action: Call Humana member services or check provider portal
Timeline: 5-10 minutes
Outcome: Confirm PA requirement and specialty pharmacy network

2. Gather Clinical Documentation

Who: Healthcare team
Action: Compile diagnosis, staging, prior therapies, labs, imaging
Timeline: 1-2 business days
Key documents: Pathology report, imaging with RECIST criteria, treatment history

3. Complete Prior Authorization Form

Who: Prescribing oncologist
Action: Submit via Humana provider portal or fax
Timeline: Same day submission recommended
Include: Medical necessity letter with NCCN guideline citations

4. Request Expedited Review (if urgent)

Who: Prescriber
Action: Certify urgent medical need in PA request
Timeline: 24-72 hours for decision vs. standard 72 hours
Criteria: Imminent health risk or disease progression

5. Follow Up and Track

Who: Patient or clinic
Action: Call Humana within 48-72 hours for status update
Get: Reference number and expected decision date
Document: All interactions with dates and representative names

6. Coordinate with Specialty Pharmacy

Who: Patient with clinic support
Action: Once approved, arrange dispensing and delivery
Timeline: 1-3 business days after approval
Monitor: First shipment and ongoing refill coordination

7. Calendar Renewal Date

Who: Patient and clinic
Action: Set reminder 30-45 days before approval expires
Prepare: Updated labs, imaging, and treatment response documentation
Typical duration: 12 months with renewal required

What You Need to Gather

Essential Clinical Information:

  • Primary diagnosis with ICD-10 code (e.g., C64.1 for renal cell carcinoma)
  • Cancer staging and histology from pathology report
  • ECOG performance status or Karnofsky score
  • Recent imaging with RECIST response criteria (if applicable)
  • Complete treatment history with dates, agents, and outcomes

Prior Therapy Documentation:

  • Previous systemic therapies tried and failed or not tolerated
  • Dates of treatment start/stop and reasons for discontinuation
  • Response assessment and progression documentation
  • Any contraindications to alternative therapies

Laboratory Values:

  • Complete blood count, comprehensive metabolic panel
  • Liver function tests (ALT, AST, bilirubin)
  • Kidney function (creatinine, eGFR)
  • Thyroid function tests (if relevant for indication)

Supporting Literature:

  • NCCN Guidelines for your specific cancer type
  • FDA prescribing information highlighting approved indications
  • Peer-reviewed studies supporting treatment choice (if off-label)

Submitting Your Request

Medical Necessity Letter Checklist

Your oncologist's letter should address these key points:

  1. Patient-specific factors: Age, performance status, comorbidities
  2. Disease characteristics: Histology, stage, molecular markers
  3. Treatment rationale: Why Cabometyx is appropriate for this patient
  4. Prior therapy summary: What was tried, outcomes, and why alternatives aren't suitable
  5. Monitoring plan: How treatment response and toxicity will be assessed
  6. Guideline support: NCCN category and recommendation level
Clinician Tip: Reference specific NCCN guideline pages and FDA labeling sections. For first-line RCC, cite the Category 1 preferred recommendation for cabozantinib plus nivolumab across all risk groups.

Submission Methods

  • Provider Portal: Fastest method with real-time tracking
  • Fax: Use Humana's PA fax numbers (verify current number via provider portal)
  • Phone: For urgent cases requiring immediate attention
  • Mail: Slowest option, not recommended for time-sensitive requests

Typical Timelines

Standard Prior Authorization:

  • Submission to decision: 72 hours (3 business days)
  • Expedited review: 24-72 hours with urgency certification
  • Additional information requested: Adds 1-3 days to timeline

Medicare Advantage Specific:

  • Part D standard: 72 hours
  • Part D expedited: 24 hours
  • Coverage determination appeal: 7 days standard, 72 hours expedited
Virginia Note: These are minimum federal requirements. Humana often processes requests faster, especially for well-documented oncology cases.

Common Denial Reasons & Solutions

Denial Reason Solution Documentation Needed
Wrong formulation Verify tablet vs. capsule prescription Corrected prescription specifying "Cabometyx tablets"
Off-label use Provide clinical justification Literature review, expert opinion, clinical trial data
Insufficient prior therapy Document treatment history Pharmacy records, infusion logs, provider notes
Missing staging information Submit complete workup Pathology report, imaging with measurements
Drug interactions Address safety concerns Medication reconciliation, monitoring plan

Appeals Process in Virginia

If your initial request is denied, Virginia offers robust appeal rights through multiple levels.

Internal Appeals (Humana)

  • Deadline: 180 days from denial notice
  • Timeline: 30 days for standard, 72 hours for expedited
  • Required: Written request with supporting documentation
  • Tip: Request peer-to-peer review with oncology specialist

External Review (Virginia SCC)

Virginia's State Corporation Commission Bureau of Insurance provides independent review:

  • Deadline: 120 days after final internal denial
  • Form: Form 216-A External Review Request
  • Timeline: 45 days standard, 72 hours expedited for urgent cases
  • Cost: Free to consumers
  • Binding: Decision is final and binding on Humana
Virginia Advantage: The state allows expedited external review for cancer treatment denials without exhausting all internal appeals—a special provision recognizing the urgency of oncology care.

From Our Advocates

"We've seen many Virginia patients succeed with Cabometyx appeals by focusing on the clinical narrative. One common pattern: initial denials for 'insufficient prior therapy' get overturned when the oncologist clearly documents why standard first-line options aren't appropriate—whether due to comorbidities, prior toxicities, or disease characteristics. The key is painting a complete clinical picture, not just checking boxes."

Costs & Savings Options

2025 Medicare Part D Costs:

  • Deductible: Up to $590
  • Out-of-pocket maximum: $2,000 (new for 2025)
  • Catastrophic coverage: 100% covered after reaching maximum

Financial Assistance:

  • Exelixis Patient Support: Check eligibility at manufacturer website
  • Medicare Prescription Payment Plan: Spread costs over 12 months
  • Extra Help (LIS): Low-income subsidy eliminates deductible
  • State programs: Virginia may have additional assistance programs

Cost Reduction Tips:

  • Enroll in Medicare Prescription Payment Plan to avoid large upfront costs
  • Apply for Extra Help if income-qualified (income limits updated annually)
  • Check if your oncology practice participates in 340B pricing

FAQ

How long does Humana prior authorization take for Cabometyx in Virginia? Standard requests: 72 hours. Expedited requests with urgency certification: 24-72 hours. Well-documented oncology requests often process faster.

What if Cabometyx isn't on my Humana formulary? Request a formulary exception with medical necessity justification. Your oncologist must demonstrate why covered alternatives aren't appropriate.

Can I get expedited appeal if my cancer is progressing? Yes. Virginia allows expedited external review (72 hours) for urgent medical situations. Your doctor must certify that delays could jeopardize your health.

Does step therapy apply to Cabometyx in Virginia? Depends on your indication and plan. First-line RCC combination therapy typically doesn't require step therapy, but monotherapy might require trying other agents first.

What happens if I move from Virginia to another state? Your Humana coverage continues, but appeal rights depend on your new state's laws. Virginia's external review process only applies to Virginia residents.

How often do I need to renew prior authorization? Typically annually. Start the renewal process 30-45 days before expiration with updated labs, imaging, and response assessment.

At Counterforce Health, we specialize in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to craft targeted, evidence-backed rebuttals. Our platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements and appeals processes, particularly for high-cost specialty medications like Cabometyx. We understand that getting life-saving cancer treatments approved shouldn't require patients to become insurance experts—that's where targeted advocacy and systematic appeals processes make the difference.

Disclaimer: This guide provides general information about insurance coverage and appeals processes in Virginia. It is not medical advice, legal advice, or a guarantee of coverage. Always consult with your healthcare provider about treatment decisions and contact Humana directly for plan-specific information. Coverage policies and procedures may change.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.